Daily FNArena News - Small Caps

Tim Boreham highlights a device used to detect pain in non-verbal patients, such as those suffering dementia and infants

Tim Boreham shines a light on freshly listed Cleo Diagnostics, in search of an effective diagnostic tool for ovarian cancer

Let’s talk about the unbreakable bond between households and their pets, and about the companies that offer exposure. Updated with today’s FY23 result release

Australia is the first country in the world to legalise the use of psychedelic drugs for mental illness

Temple & Webster seems destined for strong growth, but at a lower margin as spending increases to grab more market share

Expectations are on the rise for Life360 following second quarter results

Brokers raise target prices for Avita Medical following second quarter results amidst anticipation of exciting prospects in the outlook period

Tim Boreham outlines the rise and fall of IDT Australia, and its potential revival in the cannabis and psychedelic drug market

Analysts raise target prices for SiteMinder after management brings forward the time frame for being free cash flow positive

Oncology radiology leader Telix Pharmaceuticals is taking on the US, Tim Boreham reports